2018 Speakers
 
 
The Rx Summit annually gathers leading field experts, researchers, policy makers, and others to present a comprehensive and diverse agenda. Below are 2018 speakers.
 
 
Interested in submitting a presentation for 2019?  Click here.
 
 
 
Jim Langford
Executive Director
Georgia Prevention Project
Jim Langford, Executive Director and Co-founder of the Georgia Prevention Project (GPP), brings many years of business, public service and nonprofit experience to the organization. He has been appointed by five Georgia governors to a variety of commissions and boards in the state. He also is the founder of multiple other nonprofit organizations and initiatives. GPP — a statewide prevention program aimed at reducing the use of dangerous substances among teens and young adults — evolved from its roots as the Georgia Meth Project and accomplishes its work through awareness campaigns, educational programming and strategic partnerships with national and community based organizations. In his business life, Langford founded and managed successful high technology companies over a 20-year period. Prior to his high technology career, he was an executive of The Coca-Cola Company in Atlanta, New York, Puerto Rico and Argentina. He is a member of the Board of Councilors of the Carter Presidential Center and a former member of the Georgia Board of Natural Resources and the Georgia Humanities Council. Langford earned his undergraduate degree in journalism from the University of Georgia and his Master of Business Administration from the Harvard Business School.
United We Stand: Georgia’s Comprehensive Plan and Colorado’s Collective Impact Model


Gary Langis
Technical Assistance Specialist
Education Development Center/MassTAPP
Gary Langis’s work began in the late 1980s volunteering as part of an independent group providing underground needle exchange on the North Shore. In 1990, he began working as an outreach educator for the Healthy Streets Outreach Program in Lynn, Massachusetts. In 1991 he accepted a position as Program Manager at Noddles Island Multi Service Agency working for the HIV Benefits Advocacy Program for persons who were HIV+. In 1997, he became the HIV Program Manager for CAB Health and Recovery Services HIV program in Lynn and is currently an independent consultant. Over his 13 years working at CAB, Langis helped to develop cutting-edge HIV prevention programs that encompassed principles of harm reduction and served as a model for other programs. In 1997, he was a founding member and Board President of the New England Prevention Alliance (NEPA), a group of activists that provide independent syringe exchange and Naloxone distribution to underserved communities. Langis collaborated with the state sharing data, forms, training methods and tools that were created and developed by NEPA that contributed to the foundation of the Opioid Overdose Education and Naloxone Distribution program. NEPA has conducted civil disobedience to highlight the disparities of HIV prevention in communities including Brockton, Lawrence, Worcester and Lynn.
Opioid Prevention 2.0: Innovative Strategies for Staying Ahead of the Trends


Charlotte Lanvers
JD, Trial Attorney, Disability Rights Section, Civil Rights Division
U.S. Department of Justice
Charlotte Lanvers is a Trial Attorney in the Disability Rights Section of the Civil Rights Division at the U.S. Department of Justice (DOJ), where she enforces the Americans with Disabilities Act (ADA). From 2012-2014, Lanvers worked as a Staff Attorney at the Department of Education, Office for Civil Rights (OCR), where she helped develop Section 504 and title II guidance about Section 504 obligations to respond appropriately to the bullying of students with disabilities. Prior to joining OCR, Lanvers worked at Disability Rights Education and Defense Fund as a Skadden Fellow and Staff Attorney on cases enforcing the rights of students with diabetes to receive insulin administration at school and in class action litigation against the Social Security Administration for failing to provide effective communication to blind and visually impaired recipients and beneficiaries. Lanvers holds a bachelor's degree from Princeton University and a juris doctorate from Cornell Law School.
Opioid Use Disorders and the ADA: Eliminating Discriminatory Barriers to Treatment and Recovery


Joshua Lee
MD, MSc, Professor, Department of Population Health
New York University School of Medicine
Joshua D. Lee, MD, MSc, is an Associate Professor of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU School of Medicine. He is a clinician researcher focused on addiction pharmacotherapies, and is Director of the NYU ABAM Fellowship in Addiction Medicine. His research models the use of addiction pharmacotherapies in primary care as and criminal justice populations. He has conducted multiple National Institutes of Health and other clinical trials examining the use of extended-release naltrexone and buprenorphine opioid treatments in outpatient criminal justice involved-adults, in soon-to-be released jail inmates and in community detox settings.
Extended-Release Naltrexone vs. Buprenorphine-Naloxone: A Comparative Effectiveness Trial


Tom Leyden
MBA, Director II, Value Partnerships Program
Blue Cross Blue Shield of Michigan
Tom Leyden has over 20 years of healthcare practice transformation experience in a variety of areas, including clinical program development, value-based reimbursement, performance improvement consulting, market research, planning and business development, and marketing and communications. As Director of the Value Partnerships Program for Blue Cross Blue Shield of Michigan (BCBSM), he oversees a portfolio of 50-plus statewide comprehensive partnerships with physicians, physician groups and hospitals. Prior to joining Blue Cross, Leyden served as Vice President at MPRO (Michigan’s federally designated quality improvement organization), where he oversaw performance on its statewide Medicare contract, headed many of its programs and product lines, and oversaw its marketing, community outreach, and business development functions. Prior to MPRO, Leyden worked in a variety of capacities in healthcare in Chicago and Detroit. He has presented across America and internationally on a variety of healthcare topics for forums. Leyden received his bachelor's degree from Michigan State University and his master's degree in business administration from Wayne State University.
A Public, Private Payer Partnership to Prevent Opioid Abuse and Transform Acute Care Pain Management


Sunny Linnebur
PharmD, FCCP, FASCP, BCPS, BCGP, Professor
Skaggs School of Pharmacy and Pharmaceutical Services, University of Colorado
Sunny Linnebur, PharmD, FCCP, FASCP, BCPS, BCGP, is a Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. She received her Doctor of Pharmacy degree from the University of Kansas. She completed a PGY1 residency at the Veterans Affairs Medical Center in Denver and a PGY2 Primary Care Residency at the University of Colorado. Linnebur’s clinical practice area is in geriatrics at the University of Colorado Hospital Seniors Clinic, where she precepts pharmacy students and residents. Her research and clinical areas of interest include medication therapy management, osteoporosis, vitamin D, dementia and urologic disorders. She is an active member of the American College of Clinical Pharmacy and the American Geriatrics Society, where she serves as a member of the Board of Directors. She is a certified geriatric pharmacist. Linnebur co-chairs the Safe Disposal Work Group at the Colorado Consortium for Prescription Drug Abuse Prevention.
Safe Disposal in Colorado: A State-Led Approach


Jeffrey Locke
MPP, JD, Program Director
National Governors Association
Jeffrey Locke serves as Program Director for the National Governors Association (NGA) Center for Best Practices Homeland Security and Public Safety Division, where he focuses on issues that include criminal justice reform, public safety, juvenile justice, heroin and Rx drug abuse. Prior to joining NGA, Locke served as a volunteer in the Peace Corps in Togo, West Africa, and has worked in various capacities at the local and federal government levels. Locke holds a master’s degree in public policy from Harvard Kennedy School and a Juris Doctor from Boston College Law School. Locke originally hails from New York.
Expanding Access to Treatment for Justice-Involved Populations: Lessons Learned from States


Barry Logan
PhD, F-ABFT, Sr. Vice President of Forensic Science Initiatives, Chief Scientist
NMS Labs
Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one 100 publications and 400 presentations in forensic toxicology and analytical chemistry,
including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death. His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban Philadelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University. In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).
Fentanyl Analogues Causing the Convergence of Science and Law: The Truth of the Evolving Fentanyl Analogue Epidemic
Fentanyl Analogues: Investigation and Prosecution in the New World


Jan Losby
PhD, MSW, Team Lead, Prescription Drug Overdose Health Systems Team
Centers for Disease Control and Prevention
Jan Losby, PhD, MSW, is the Team Lead for the Prescription Drug Overdose Health Systems Team in Center for Disease Control and Prevention (CDC) Division of Unintentional Injury Prevention. This team is responsible for implementing the CDC prescribing guideline in clinical settings, conducting applied health systems research, and providing scientific support to state public health departments. Prior to joining CDC, Dr. Losby managed the evaluation arm of a nonprofit evaluation organization where she designed and conducted evaluations of social service and public health programs in welfare reform, asset development, refugee services, mental health, substance abuse and employment.
Using EHR-Based Clinical Decision Supports to Affect Opioid Prescribing Behavior
CDC Guideline: Implementing Clinical and Practice-Level Strategies


Kathryn Lowerre
PhD, MPH, Evaluator
New Mexico Department of Health
Dr. Kathryn Lowerre joined the New Mexico Department of Health (NMDOH) in 2014 as the Bureau Evaluator for Environmental Health Epidemiology, working with multiple Centers for Disease Control and Prevention-funded programs engaging stakeholders and presenting evaluation findings to a range of audiences. In April 2016 she moved to NMDOH’s Prescription Drug Overdose Prevention Program. Previous positions include college and university teaching appointments, as well as work at county and regional health departments on health impact assessments and population health indicators and in drug regulatory affairs as a consultant. Her first health-related position, in clinical trials coordination, was at the Duke AIDS Research and Treatment Center, where she volunteered and worked part-time while completing her doctorate.
Implementation and Evaluation of New Mexico’s PDMP Mandate Legislation in Context


William Lynch
RPh, BPharm, Clinical Staff Pharmacist
Jefferson Health System, atTAcK addiction and Camden County (New Jersey) Addiction Awareness Task Force
William Lynch, RPh, BPharm, received his pharmacy degree from Rutgers University and is a practicing Clinical Staff Pharmacist with Kennedy University Hospital (KUH), the major core teaching affiliate with the Rowan School of Osteopathic Medicine (RSOM), where he serves as Adjunct Clinical Faculty. His pharmacy background includes more than 30 years of clinical practice at KUH/RSOM and as a clinical preceptor for Rutgers University, Ernest Mario School of Pharmacy, along with being a healthcare professional partner of the Delaware Prevention Coalition and State of Delaware Substance Abuse Epidemiological Working Group. Lynch is a member of the Camden County New Jersey Addiction Awareness Task Force (CCAATF), where he co-chairs the Education and Prevention Committee, and he is an Advisory Board Member with atTAcK addiction. Lynch is a certified New Jersey Department of Law and Public Safety Division of Criminal Justice Police Training Commission Instructor. He is the overnight clinical staff pharmacist at KUH, which specializes in behavioral medicine providing pediatric, adolescent, and adult psychological care, 24/7 crisis intervention, and drug and alcohol detoxification and treatment services.
Changing Attitudes: Law Enforcement, Public Health and Naloxone


Kent MacLennan
MA, Executive Director
Rise Above Colorado
Kent MacLennan is proud to lead the organization into its next phase as the Executive Director of Rise Above Colorado. As the founding Executive Director for the Colorado Meth Project, he has overseen local public service messaging, public policy, fundraising and community outreach efforts to reduce first-time meth use. In May 2009, Colorado was the sixth of eight states to adopt the Meth Project, which as been nationally recognized for its extensive research, integrated media campaign and proven results. MacLennan has more than 20 years of progressive leadership experience in the nonprofit sector. He spent nearly 15 years in the development field for youth-serving and educational organizations, including Young Amercias Center for Financial Education, the University of Denver and Up With People. He has direct experience working with the teenage demographic targeted by the Colorado Meth Project, having taught social studies for two years at Pomona High School in Arvada. MacLennan holds a bachelor's degree in foreign service from Georgetown University and a master's degree in education from the University of Denver.
Colorado AmeriCorps Community Opioid Response Program


Cydney Maddox
Member, Teen Advisory Council
Georgia Prevention Project
Cydney Maddox is a senior at Lassiter High School, and she is President of the school's Teen Advisory Council (TAC) chapter. In her own words: "In TAC, we implement community level change strategies to combat the growing rate of prescription drug abuse and addiction in our community. Ever since I first got involved in TAC during my sophomore year, I have been able to make a tremendous difference in the lives of my neighbors and peers. My passion for prevention stems from Kaitlin Merchan’s and Connor Nettels’s belief that individual students can be leaders and make a difference. Drug prevention is so important to me personally, that is the subject of my Gold Award. Outside of school, I like to serve my community in Girl Scouts and learn about languages and cultures. I hope to attend Hampton University this fall, majoring in international studies and minoring in Spanish."
Prevention for Youth, by Youth


Andrea Magermans
Prescription Drug Monitoring Program Managing Director
Wisconsin Department of Safety and Professional Services
Andrea Magermans is currently the Managing Director of the Wisconsin Prescription Drug Monitoring Program (WI PDMP) at the Wisconsin Department of Safety and Professional Services. She joined the department in December 2012 as a Program and Policy Analyst to oversee the training and outreach efforts for the launch of the WI PDMP in 2013. Since then, she collaborated as Deputy Managing Director on all aspects of the operations and enhancement of the WI PDMP, including the development of the Wisconsin Enhanced Prescription Drug Monitoring Program in 2017. She became Managing Director in September 2017.
PDMP Innovations: Washington’s Prescriber Feedback and Wisconsin’s Data Analytics


Ajay Manhapra
MD, Physician, Research Scientist, Lecturer
Hampton VA Medical Center, New England Mental Illness Research, Education and Clinical Center, Yale School of Medicine
Dr. Ajay Manhapra was a practicing hospitalist managing complexly ill patients for over a decade before he made a career transition to addiction medicine and research. After a two-year VA-funded fellowship at Yale University, he started a primary care based clinic for patients with severe chronic disabling pain who have failed several treatment interventions. The clinic follows a whole-person approach to help these patients recover their functional life. In the clinic, they focus on multimorbidity as the main target of pain treatment, combining medical and psychiatric care, treatment of dependence and addiction, and polypharmacy management with behavioral treatment of pain. He also continues his research related to addiction and comorbidities through his affiliations at Yale School of Medicine and VA New England MIRECC.
Surprising VA Data About Opioid Discontinuation, Overdose and Suicide: Clinical Implications


Denise Mariano
Consultant and Parent Coach
Partnership For Drug-Free Kids
Denise Mariano’s work and advocacy efforts spread far and wide, however, her focus remains on advocating for and supporting families impacted by substance use disorder. She has been a strong voice for families at the national and state levels since, 2011. Mariano was selected and honored at the White House as an Advocate for Action, where she was recognized as one of the leaders across the country making a difference. She also was selected as a National Council on Alcoholism and Drug Dependence Advocacy Leader for her efforts in New Jersey. Mariano is a Peer Parent Coach at the Partnership for Drug-Free Kids and works within the Parent Support Network, where she helps develop and promote programs to support families struggling with substance use disorders and to encourage healthier behaviors and improve family cohesion. This work is based upon Community Reinforcement and Family Training, or CRAFT, and Motivational Interviewing, evidence-based models. She also serves as an Ambassador for the Partnership. Mariano is a member of her County Task Force on Opiates, a member of Faces and Voices, D.C. Program Outreach Committee and a member of New Jersey’s Experience, Hope and Strength Recovery High School Fund Raising Committee.
Empowering Families: How to Address a Loved One’s Opioid Use and Become a Family Advocate


Edward J. Markey
U.S. Senator
(D-MA)
Senator Edward J. Markey, a consumer champion and national leader on energy, environmental protection and telecommunications policy, has a prolific legislative record on major issues across the policy spectrum and a deep commitment to improving the lives of the people of Massachusetts and our country. Whether the issue is climate change, clean energy, safeguarding privacy, nuclear non-proliferation, investor protection or preserving an open Internet that spurs competition and consumer choice, Senator Markey stands up for the priorities and values of Massachusetts. Markey Headshot High Resolution


While serving for 37 years in the U.S. House of Representatives, Senator Markey fought for his constituents throughout his Congressional District. When he was Dean of the Massachusetts delegation in the House, he worked to harness the energy and influence of his colleagues on behalf of the entire Commonwealth. Elected to the Senate in a special election in June 2013, Senator Markey is bringing his experience, energy and expertise to fight for all the people of Massachusetts.

Senator Markey has amassed an unparalleled record of energy and environmental legislative achievements. He has consistently fought to create new jobs in American clean energy and served as a leading consumer champion against rising gas prices and foreign oil. He is the principal House author of the 2007 fuel economy law, which will increase fuel economy standards to 54.5 miles per gallon by 2025, the first increase in a generation. He also is the author of the appliance efficiency act of 1987, which stopped the construction of hundreds of coal-fired plants. Senator Markey authored the law that established the Northeast Home Heating Oil Reserve, ensuring that New England families won't be left out in the cold when oil prices spike. And he is the author of the revolutionary law that requires electricity regulators to open up the wholesale electric power market for the first time.

In 2009, Congressman Markey was the co-author of the landmark Waxman-Markey bill, the only comprehensive climate legislation ever to pass a chamber of Congress. It gave hope to the world that the United States was serious about addressing climate change and helped America effectively negotiate with the international community.

Senator Markey was a leading voice in the investigation into the BP oil spill. He insisted that the company reveal the true size of the spill's flow rate, raised concerns about the use of toxic chemical dispersants into the environment and forced BP to make live video footage of the oil spill available to the public on the "Spillcam" website he created. BP ultimately pled guilty to 14 counts, including one count of Obstruction of Congress for making false and misleading statements and withholding information and documents from then-Rep. Markey about the true size of the spill.

In the House of Representatives, Congressman Markey served as the Ranking Member of the Natural Resources Committee. From 2007 to 2010, he served as Chairman of the Select Committee on Energy Independence and Global Warming, a signature committee established by then-Speaker Nancy Pelosi. He also served on the Energy and Commerce Committee, where he was Chairman of the Subcommittee on Energy and the Environment.

A member of the Commerce, Science and Transportation Committee, Senator Markey is a national leader on telecommunications policy, technology and privacy. In the House, he served for 20 years as Chair or Ranking Member of the Subcommittee on Telecommunications and the Internet, where he fostered the growth of new information technologies and was the principal author of many of the laws now governing our nation's telephone, broadcasting, cable television, wireless, and broadband communications systems. He is the House author of the 1992 Cable Act, which increased choices for millions of consumers and enabled satellite-delivered programming to be more widely offered.

He also authored the law in 1993 that moved over 200 MHz of spectrum from government to commercial use, creating the 3rd, 4th, 5th, and 6th wireless phone companies. New companies entered the market with digital technology, forcing the incumbents to innovate and invest and pushing mobile phone prices down.

Congressman Markey authored the landmark Telecommunications Act of 1996, ushering competition into the telecommunications marketplace and unleashing private sector investment.

Competition remains Senator Markey's economic mantra, in his words, "ruthless Darwinian competition that would bring a smile to Adam Smith." He has been instrumental in breaking up anti-consumer, anti-innovative monopolies in electricity, long-distance and local telephone service, cable television, and international satellite services. He was one of the only members of the House Commerce Committee to fight AT&T's monopoly in the early 1980s and is a principal author of the requirement that the Bell Operating companies accept local telephone service in the 1990s. His pro-competition policies have directly benefited job creation in Massachusetts and throughout the country.

While in the House, Congressman Markey introduced the Internet Freedom Preservation Act, the first net neutrality bill introduced in Congress, to ensure that as the Internet continues to evolve, it remains a level playing field guided by the principles of openness, competition and innovation. He also has been a key leader on providing privacy protections for personal information such as medical records, financial records, and on-line purchases. He has championed strengthening privacy protections for children and is the House author of the Children's Online Privacy and Protection Act (COPPA), the primary law that safeguards children's privacy online.

From 2003 to 2009 in the House of Representatives, Senator Markey also served as a senior member of the Homeland Security Committee. In that capacity, he focused on closing gaps in our homeland defenses, particularly in the areas of nuclear, aviation, maritime, liquefied natural gas and chemical security. In the wake of the 9-11 attacks, he authored the first-ever mandate in the law that 100% of cargo on passenger planes is screened, and 100% of all maritime cargo is scanned before entering America's ports.

Senator Markey also was the leader of the national Nuclear Freeze movement and has been a Congressional champion on nuclear nonproliferation. His amendment to ban all underground nuclear testing passed in 1986, and in the 1990s, he fought to tighten controls on global trafficking in nuclear technology. Since then, Senator Markey has continued his work on nuclear nonproliferation, successfully enacting new restrictions on exports of nuclear and dual-use technologies to Iran, North Korea, and other countries designated as state sponsors of terrorism and pressing for stronger nuclear nonproliferation conditions on all future nuclear trade cooperation agreements As founder of the Nonproliferation Caucus, Senator Markey continues to spearhead efforts to prevent the spread of nuclear weapons to safeguard the future for generations to come.

He is the author of some of the most important Wall Street reform laws since the Great Depression, including statutes that strengthened penalties against insider trading, improved federal oversight over the stock and futures markets, and reformed regulation of the government securities market.

Senator Markey was born in Malden, Massachusetts, on July 11, 1946. He attended Boston College (B.A., 1968) and Boston College Law School (J.D., 1972). He served in the U.S. Army Reserve and was elected to the Massachusetts State House where he served two terms representing Malden and Melrose. He is married to Dr. Susan Blumenthal.
Plenary Session: Congressional Leaders Update


Joe Markiewicz
Senior Consultant
Building Stronger Communities
Joe Markiewicz is the Senior Consultant at Building Stronger Communities. Recently, he was the Program Coordinator for the Statewide Prescription Drug Overdose Reduction Initiative at the University of Kentucky. He has over 20 years' experience as a community coalition trainer, prevention planner, evaluator and youth trainer. He has been a presenter at national conferences on the subject of risk and protective factors, evidenced-based prevention strategies, youth data, community planning and positive social norming. In 2012, Markiewicz received the Erie County Award for Youth Violence Reduction and as Chair of the Erie County Collaborative Board he received the Statewide Community Coalition of the Year Award in Pennsylvania. In his previous employment, Markiewicz was a statewide planner and trainer with the Center for Juvenile Justice Training & Research, Pennsylvania Commission on Crime and Delinquency, and Juvenile Court Judge’s Commission, as well as many other youth-serving organizations. He is also a national technical assistant for the Office of Juvenile Justice Training & Research (OJJTR).
Prevention for Youth, by Youth


Patrick Marshalek
MD, Associate Professor, Clinical Faculty
School of Medicine, West Virginia University
Dr. Patrick Marshalek is a psychiatrist and Associate Professor at West Virginia University (WVU) School of Medicine with specialties in behavioral medicine and psychiatry. He is board certified in psychiatry and has multiple clinical appointments at WVU and within the surrounding community, including the Chestnut Ridge Center West Virginia University, a leading regional referral center for treatment of mental health and addiction disorders. Through these appointments, Marshalek directs multiple teams, including telepsychiatry and pain resource management. His expertise includes use of telehealth and delivery of substance abuse treatment, including office-based medication assisted treatment. Marshalek has presented and published extensively on addiction medicine.
Expanding Access to OUD Treatment: The Role of Telehealth


Brandon Marshall
PhD, Associate Professor
Brown University
Dr. Brandon Marshall is an Associate Professor of Epidemiology at the Brown University School of Public Health. Broadly, his research focuses on HIV/AIDS, substance use epidemiology, and the social, environmental, and structural determinants of health of urban populations. He is the inaugural recipient of the National Institute on Drug Abuse "Avenir" award, which supports a research program using agent-based modeling to investigate HIV transmssion dynamics among people who use drugs and involved in a number of other NIH and CIHR-funded cohort studies of people who use drugs, street-involved youth and men who have sex with men. Marshall is also the Associate Public Health & Epidemiology Editor of the International Journal of Drug Policy.
Drug Checking: A Novel Evidence-Based Strategy for Preventing Overdose